Results 1 to 10 of about 67,305 (212)

Cytotaxonomy of Trypanosoma cruzi (Chagas, 1909): Differentiation of T. cruzi I (TcI) and T. cruzi II (TcII) Genotypes Using Cytogenetic Markers. [PDF]

open access: yesAm J Trop Med Hyg, 2019
Chagas disease is a public health problem caused by the Trypanosoma cruzi, and the T. cruzi I (TcI) and T. cruzi II (TcII) groups are considered important genotypes from the clinical point of view. Currently, the groups need to be molecularly analyzed for their identification; thus, we cytogenetically analyzed these groups with the objective of ...
Oliveira ABB   +6 more
europepmc   +5 more sources

Protective role of TRPV1+ nociceptive neurons communication to macrophages against T. cruzi infection in mice [PDF]

open access: yesBrain, Behavior, & Immunity - Health
Chagas’ disease is a life-threatening condition caused by Trypanosoma cruzi. Patients with chronic disease may develop gastrointestinal, neurological, or associated neuro-digestive dysfunctions. CNS invasion by T.
Sergio M. Borghi   +11 more
doaj   +2 more sources

Astrocyte Apoptosis and HIV Replication Are Modulated in Host Cells Coinfected with Trypanosoma cruzi [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2017
The protozoan Trypanosoma cruzi is the etiological agent of Chagas disease. In immunosuppressed individuals, as it occurs in the coinfection with human immunodeficiency virus (HIV), the central nervous system may be affected. In this regard, reactivation
Javier M. Urquiza   +11 more
doaj   +3 more sources

Cardiomyocyte oxidants production may signal to T. cruzi intracellular development. [PDF]

open access: yesPLoS Negl Trop Dis, 2017
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, presents a variable clinical course, varying from asymptomatic to serious debilitating pathologies with cardiac, digestive or cardio-digestive impairment. Previous studies using two clonal T. cruzi populations, Col1.7G2 (T. cruzi I) and JG (T.
Dias PP   +7 more
europepmc   +5 more sources

Assessing anti-T. cruzi candidates in vitro for sterile cidality. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist, 2016
Total clearance of the T. cruzi infection - referred to herein as "sterile cure" - seems to be a critical prerequisite for new drug candidates for Chagas disease, ensuring long-term beneficial effects for patients in the chronic indeterminate stage. This requirement is notably supported by the recent findings of clinical studies involving posaconazole ...
Cal M   +4 more
europepmc   +5 more sources

Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. [PDF]

open access: yesPLoS Pathogens, 2006
Acquisition of detailed knowledge of the structure and evolution of Trypanosoma cruzi populations is essential for control of Chagas disease. We profiled 75 strains of the parasite with five nuclear microsatellite loci, 24Salpha RNA genes, and sequence ...
Jorge M de Freitas   +11 more
doaj   +2 more sources

Trypanosoma cruzi-infected triatomines and rodents co-occur in a coastal island of northern Chile [PDF]

open access: yesPeerJ, 2020
Trypanosoma cruzi, the cause agent of Chagas disease, is transmitted mainly by blood-feeding insects of the subfamily Triatominae. The T. cruzi life cycle alternates between triatomines and mammalian hosts, excluding birds and reptiles.
Ricardo Campos-Soto   +5 more
doaj   +2 more sources

Trypanosoma cruzi infection in neotropical wild carnivores (Mammalia: Carnivora): at the top of the T. cruzi transmission chain. [PDF]

open access: yesPLoS ONE, 2013
Little is known on the role played by Neotropical wild carnivores in the Trypanosoma cruzi transmission cycles. We investigated T. cruzi infection in wild carnivores from three sites in Brazil through parasitological and serological tests.
Fabiana Lopes Rocha   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy